Skip to content
← Clinical Cases

Compounding I: Basics — clinical cases

29 questions

Sample cases

  1. Case 1

    A US hospital pharmacy compounds all of its sterile preparations in a certified ISO Class 5 laminar airflow workbench that sits in an unclassified segregated compounding area (SCA); it has no cleanroom suite. A 66-year-old man (82 kg, creatinine 97 µmol/L (1.1 mg/dL)) with vertebral osteomyelitis needs a vancomycin infusion at a non-standard concentration, made from sterile vials and a sterile diluent bag. This is compounding, not preparation per approved labeling, and stability data support at least 7 days under refrigeration.

    According to USP <797> (2023), what is the longest beyond-use date (BUD) that may be assigned if the bag is stored in a refrigerator?

    • A.12 hours
    • B.24 hours
    • C.4 days
    • D.10 days
  2. Case 2

    A US home-infusion pharmacy has a cleanroom suite (ISO Class 5 PEC in an ISO Class 7 buffer room with an ISO Class 8 anteroom) and meets the requirements for Category 2, but not Category 3, CSPs. For a 54-year-old woman with a prosthetic-joint infection (creatinine 71 µmol/L (0.8 mg/dL)), it aseptically compounds an antibiotic infusion from sterile starting components only. No sterility test is performed. Published stability data for this exact formulation support 21 days under refrigeration. Compounding begins at 14:00 on 3 March 2027 and the finished infusion is stored in a refrigerator.

    According to USP <797> (2023), what is the latest BUD that may be assigned?

    • A.7 March 2027 at 14:00
    • B.12 March 2027 at 14:00
    • C.13 March 2027 at 14:00
    • D.17 March 2027 at 14:00
  3. Case 3

    A pharmacy technician has just been hired to prepare non-hazardous sterile preparations in a hospital cleanroom. She has finished the didactic training and passed the written test on the pharmacy's procedures.

    Under both the NAPRA Model Standards and USP <797>, what must she also pass before she may compound sterile preparations on her own?

    • A.Gloved fingertip sampling and a media-fill test of her aseptic technique
    • B.A sterility test on each of the first five preparations she makes
    • C.Viable air sampling of the buffer room taken while she is compounding
    • D.Direct observation of ten preparations by a pharmacist, without testing